Additional studies are required to determine the mechanisms underlying the decreased expression of CXCL3 in endocan siRNA silenced PC-3 cells, and more research is needed to ascertain the biological role of ESM-1 in prostate cancer. This evidence concerns the gene ESM1 and prostate cancer.